Pembrolizumab

Overall survival with Pembrolizumab in early-stage TNBC – Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X:

“Check out this Practice Update commentary from Dr. Stefania Morganti and Dr. Sara Tolaney  on overall survival with Pembrolizumab in early-stage TNBC.

Overall Survival With Pembrolizumab in Patients With Early-Stage TNBC

Authors: Stefania Morganti, Sara M. Tolaney.”

Overall survival with Pembrolizumab in early-stage TNBC - Dana-Farber’s Breast Oncology Center

 

cancer early-stage TNBC OncoDaily Oncology pembrolizumab Sara Tolaney Stefania Morganti